Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers Squibb: The Rerating Was Fast - The Proof Will Be Slow (Rating Downgrade)
11:52am, Saturday, 24'th Jan 2026
Bristol Myers Squibb (BMY) has delivered a ~27% total return in three months, driven by topline growth and dividend strength. With the valuation rebound largely complete, BMY shifts from a high-convic
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.
06:30pm, Friday, 23'rd Jan 2026
Bristol Myers Squibb just announced an important partnership with Microsoft that involves AI. Intuitive Surgical has integrated AI real-time processing into its surgical robots, but that could be just
Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion
03:52pm, Friday, 23'rd Jan 2026
Bristol-Myers Squibb (BMY) remains a Strong Buy as it accelerates Growth Portfolio revenues and executes strategic oncology expansion. BMY's collaboration with Janux Therapeutics positions it to enter
Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million
02:02pm, Thursday, 22'nd Jan 2026
Janux Therapeutics, Inc. (NASDAQ: JANX) on Thursday announced a collaboration and exclusive worldwide license agreement with Bristol Myers Squibb Co. (NYSE: BMY).
Is BMY's Deep Pipeline the Key to Its Next Growth Phase?
10:16am, Thursday, 22'nd Jan 2026
BMY spotlights a deep pipeline with multi-billion-dollar potential, key late-stage data readouts ahead, and encouraging uptake of the new schizophrenia drug Cobenfy.
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
07:38am, Thursday, 22'nd Jan 2026
Janux Therapeutics said on Thursday it has entered a collaboration with Bristol Myers Squibb to develop a new cancer treatment, sending its shares up more than 12% in premarket trading.
Top 10 Dividend Stocks For Uncertain Times
05:00am, Thursday, 22'nd Jan 2026
Stocks entered 2026 on a positive note before a global sell-off wiped out gains, driven by tariff tensions, a Greenland tug-of-war, and Japan's bond crisis. In this uncertain environment, dividends ca
Final Trade: BMY, IGV, SOXX, GEN, AMZN
06:17pm, Wednesday, 21'st Jan 2026
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.
The Best Stocks to Invest $1,000 in Right Now
11:45am, Wednesday, 21'st Jan 2026
The S&P 500 index is near all-time highs and has a low dividend yield of 1.1%. The stock market is narrowly focused on a few large technology companies.
Market Today: Netflix's WBD Bid, Tech Selloff, AI at Davos
05:35pm, Tuesday, 20'th Jan 2026
Guru Stock PicksChuck Royce has made the following transactions:Reduce in APYX by 1.27%Add in EBF by 4.13%New position in ANDGSmead Value Fund has made the foll
BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now?
02:42pm, Tuesday, 20'th Jan 2026
Bristol Myers Squibb BMY and GSK PLC GSK are among the largest global biopharma companies with broad and diverse portfolios.
Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool
01:02pm, Tuesday, 20'th Jan 2026
Bristol Myers Squibb partners with Microsoft to use AI imaging tools to detect lung cancer earlier and support radiologists.
2 Top Blue-Chip Stocks to Buy and Hold in 2026
11:00am, Tuesday, 20'th Jan 2026
The undervalued stocks of these reliable large companies look attractive today.
3 Dividend Income ETFs That Offer High Yields And Growth
09:50am, Tuesday, 20'th Jan 2026
Dividend income ETFs simplify stock investing and give you plenty of cash flow. These ETFs tend to have high yields and diversified portfolios that prioritize blue-chip stocks.
Bristol Myers partners with Microsoft for AI-driven lung cancer detection
08:08am, Tuesday, 20'th Jan 2026
Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology platform to help speed up early detection of lung cancer.
